Drug Type Small molecule drug |
Synonyms Berberine Tannas, Berberine tannate (JP17), Berberine Tannate Pellicles + [4] |
Mechanism Cholesterol modulators, α-adrenergic receptor antagonists(Alpha adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18NO4 |
InChIKeyYBHILYKTIRIUTE-UHFFFAOYSA-N |
CAS Registry2086-83-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Phase 2 | US | 30 May 2019 |